Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmacognosy Journal is Scopus-indexed (Q3, CiteScore 2.5). Published by EManuscript Technologies.
Checked against the index lists dated .
ISSN 0975-3575Verify ISSN ↗
Publisher: EManuscript Technologies
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 232 / 328 | 29th | Q3 |
| Drug Discovery | 121 / 161 | 25th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q3, CiteScore 2.5.
Pharmacognosy Journal is Q3 in Pharmacology (rank 232 of 328) and Q3 in Drug Discovery (rank 121 of 161), by CiteScore 2025.
Pharmacognosy Journal is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.5, quartile Q3, 29th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.206, quartile Q4, with an H-index of 43.
Pharmacognosy Journal is published by EManuscript Technologies. Its ISSN is 0975-3575.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pharmacognosy Journal has an h-index of 49 and a 2-year mean of 1.21 citations per paper (OpenAlex). Its Scopus CiteScore is 2.5, quartile Q3. On 2-year citations it ranks #219 of 319 Scopus journals in Pharmacology.
Pharmacognosy Journal published 103 papers in 2025; its busiest recent year was 2020 with 282. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 90 research articles (2025–2026), authors are most often from Indonesia (31.1%), India (25.6%) and South Africa (10%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.